Loading live market data…

ChitogenX Inc.

CNQ:CHGX.CN

$0.005 CAD

$0 (0.0%)

Volume
120K
Average Volume
31.62K
Market Capitalization
$415.65K
P/E Ratio
-0.23
Dividend Yield
0.00%
Price Target
$
Year High
$0.05
Year Low
$0.01
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.07

Industry, Sector & symbol

Stock Exchange CNQ
CEO Pierre Laurin
Industry Biotechnology
Sector Healthcare
Current Symbol CHGX.CN
CUSIP 169916103
CIK None
Web https://www.chitogenx.com
Phone 514-782-0951
Currency CAD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.63
Payout Ratio 0.00
Current Ratio 0.07
Quick Ratio 0.07
Cash Ratio 0.01

Sales & Book Value

Annual Sales $-
Price / Sales 0.00
Cash Flow -0.01
Price / Cash Flow -0.41
Price / Book -0.06

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0213
Trailing P/E Ratio -0.23
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-1.55M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity 19.40%
Return on Assets -291.01%

Financials Score

AltmanZ Score -135.06
Piotroski Score 2.00
Working Capital -7.52M
Total Assets 385K
Ebit -1.23M
Market Cap 415.65K
Total Liabilities 7.75M

Poll Results

About ChitogenX Inc. (CNQ:CHGX.CN) Stock

ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada. ...

Frequently Asked Questions

What is the current ChitogenX Inc. (CHGX.CN) stock price?

ChitogenX Inc.(CNQ:CHGX.CN) stock price is $0.005 in the last trading session. During the trading session, CHGX.CN stock reached the peak price of $0.045 while $0.005 was the lowest point it dropped to. The percentage change in CHGX.CN stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHGX.CN stock was $0.

CHGX.CN's industry and sector of operation?

The CNQ listed CHGX.CN is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of CHGX.CN?

Benedek Simo | Controller
Jonathan Sackier | Senior Vice President of Medical Affairs
Frédéric Dumais | Director of Communications & Investor Relations
Guy-Paul Allard | Vice President of Legal Affairs & Corporate Secretary
Luc Mainville | Senior Vice President & Chief Financial Officer

How many employees does CHGX.CN have?

Number of CHGX.CN employees currently stands at None. CHGX.CN operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.

Link for CHGX.CN official website?

Official Website of CHGX.CN is: https://www.chitogenx.com

How do I contact CHGX.CN?

CHGX.CN could be contacted at phone #514-782-0951 and can also be accessed through its website. CHGX.CN operates from 16667 Hymus Boulevard, Kirkland, QC H9H 4R9, CA.

How many shares of CHGX.CN are traded daily?

The average number of CHGX.CN shares traded daily for last 3 months was 31.62K.

What is the market cap of CHGX.CN currently?

The market value of CHGX.CN currently stands at $415.65K with its latest stock price at $0.005